Toronto, Canada
MDBiologix is a leading company in the field of Regenerative Medicine, striving to bring innovation and life-changing therapies to patients seeking recovery from chronic pain, trauma, or aging. The company's commitment to advancing patient care is realized through equipping physicians with solutions and knowledge to enhance outcomes. MDBiologix achieves this through offering approved medical devices from esteemed manufacturers, providing physician education, and extending clinical support.
The company's focus on Autologous Biologics including Platelet-Rich Plasma (PRP) Therapy, Stem Cell Therapy (e.g., Bone Marrow Aspirate and Adipose-Derived), and Autologous Cytokine-Rich Serum (ACRS) for regenerative purposes underscores its dedication to cutting-edge innovation. In addition to these biologics, MDBiologix also provides a range of Application Devices such as Mesotherapy & Carboxyl Therapy Injection Device(s), Microneedling Devices, and Liquid Applicator Devices.
Founded in 2003, MDBiologix operates in the Health Care, Manufacturing, and Pharmaceutical sectors. The company's commitment to advancing regenerative medicine and improving patient outcomes positions it as an attractive prospect for potential investors or partners seeking to contribute to the advancement of healthcare.
For those interested in learning more about MDBiologix or exploring opportunities, visit their website at www.mdbiologix.com.
